Cytocast has been accepted to be part of the Central Europe Deeptech Startup Map. We are happy to be included in the deep-tech healthcare ecosystem developing technologies and products on the basis of scientific progress and high-tech innovation. 

Deep-tech developments in the healthcare industry have gained momentum, and it has the potential to change healthcare for the better, for example by allowing us to develop highly personalized treatments for individuals. 

To learn more about our company, visit Cytocast‘s website, and if you want to explore the deep tech ecosystem, you should visit Aper Ventures.